Due nuovi, promettenti studi Lultimo in ordine di tempo, uscito sul New England Journal of Medicine , ha rilevato la capacit della semaglutide di ridurre il rischio di gravi problematiche renali e di morte per cause cardiovascolari nei diabetici di tipo 2 con malattia renale cronica
Takiguchi H, Yang CX, Yang CWT, et al
Exenatide treatment exerts anxiolytic- and antidepressant-like effects and reverses neuropathy in a mouse model of type-2 diabetes
Connect with IQVIA to explore whats next in the obesity market
Oxid Med Cell Longev 2013, 972913.CrossRefGoogle ScholarPubMed
Endogenous (naturally produced) HGH surges during sleep and intense physical activity, but levels begin to decline significantly with age